» Articles » PMID: 34179310

Tumor Suppressor P53 Cross-talks with TRIM Family Proteins

Overview
Journal Genes Dis
Date 2021 Jun 28
PMID 34179310
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

p53 is a key tumor suppressor. As a transcription factor, p53 accumulates in cells in response to various stress signals and selectively transcribes its target genes to regulate a wide variety of cellular stress responses to exert its function in tumor suppression. In addition to tumor suppression, p53 is also involved in many other physiological and pathological processes, e.g. anti-infection, immune response, development, reproduction, neurodegeneration and aging. To maintain its proper function, p53 is under tight and delicate regulation through different mechanisms, particularly the posttranslational modifications. The tripartite motif (TRIM) family proteins are a large group of proteins characterized by the RING, B-Box and coiled-coil (RBCC) domains at the N-terminus. TRIM proteins play important roles in regulation of many fundamental biological processes, including cell proliferation and death, DNA repair, transcription, and immune response. Alterations of TRIM proteins have been linked to many diseases including cancer, infectious diseases, developmental disorders, and neurodegeneration. Interestingly, recent studies have revealed that many TRIM proteins are involved in the regulation of p53, and at the same time, many TRIM proteins are also regulated by p53. Here, we review the cross-talk between p53 and TRIM proteins, and its impact upon cellular biological processes as well as cancer and other diseases.

Citing Articles

The impact of dysregulation SUMOylation on prostate cancer.

Li K, Wang H, Jiang B, Jin X J Transl Med. 2025; 23(1):286.

PMID: 40050932 PMC: 11887156. DOI: 10.1186/s12967-025-06271-2.


The critical role of TRIM protein family in intervertebral disc degeneration: mechanistic insights and therapeutic perspectives.

Li S, Jiang W, Chen F, Qian J, Yang J Front Cell Dev Biol. 2025; 13:1525073.

PMID: 39981097 PMC: 11839679. DOI: 10.3389/fcell.2025.1525073.


p53: The Multifaceted Roles of Covalent Modifications in Cancer.

Grigoreva T, Romanova A, Tribulovich V, Pestov N, Oganov R, Kovaleva D Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770524 PMC: 11677429. DOI: 10.3390/ph17121682.


TRIM25, TRIM28 and TRIM59 and Their Protein Partners in Cancer Signaling Crosstalk: Potential Novel Therapeutic Targets for Cancer.

Chiang D, Yap B Curr Issues Mol Biol. 2024; 46(10):10745-10761.

PMID: 39451518 PMC: 11506413. DOI: 10.3390/cimb46100638.


STK40 inhibits trophoblast fusion by mediating COP1 ubiquitination to degrade P57.

Li X, Shao L, Li Z, Wang Y, Cai Q, Wang S J Transl Med. 2024; 22(1):852.

PMID: 39304928 PMC: 11414097. DOI: 10.1186/s12967-024-05360-y.


References
1.
Dai X, Geng F, Li M, Liu M . Tripartite motif‑containing 11 regulates the proliferation and apoptosis of breast cancer cells. Oncol Rep. 2019; 41(4):2567-2574. DOI: 10.3892/or.2019.7015. View

2.
Yue X, Zhao Y, Xu Y, Zheng M, Feng Z, Hu W . Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy. J Mol Biol. 2017; 429(11):1595-1606. PMC: 5663274. DOI: 10.1016/j.jmb.2017.03.030. View

3.
Li B, Zhou T, Zou Y . Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome. Mol Genet Genomic Med. 2016; 4(1):95-105. PMC: 4707030. DOI: 10.1002/mgg3.183. View

4.
Zhang J, Zhou Y, Yu Z, Chen A, Yu Y, Wang X . Identification of core genes and clinical roles in pregnancy-associated breast cancer based on integrated analysis of different microarray profile datasets. Biosci Rep. 2019; 39(6). PMC: 6591572. DOI: 10.1042/BSR20190019. View

5.
Zhang P, ElAbd S, Hammer S, Solozobova V, Yan H, Bartel F . TRIM25 has a dual function in the p53/Mdm2 circuit. Oncogene. 2015; 34(46):5729-38. DOI: 10.1038/onc.2015.21. View